Pathology · Hematological Malignancies (Leukemias, Lymphomas, Myeloma)

A bone marrow biopsy from a 65-year-old man with unexplained anemia shows increased plasma cells (>60%) with a monotypic kappa light chain. His serum protein electrophoresis reveals an M-spike in the gamma region. Serum free light chain ratio is markedly abnormal. According to IMWG 2014 criteria, which single finding alone qualifies as a 'myeloma-defining event' without end-organ damage?

  • A Serum M-protein ≥3 g/dL
  • B Bone marrow plasma cells ≥60%
  • C Bence-Jones proteinuria >1 g/24h
  • D Serum beta-2 microglobulin elevation
Correct answer: B. Bone marrow plasma cells ≥60%

Explanation

The IMWG 2014 revised criteria added 'SLiM-CRAB' myeloma-defining events to allow treatment before overt end-organ damage. The 'SLiM' biomarkers are: bone marrow plasma cells ≥60% ('S' is for sixty), serum involved/uninvolved free light chain ratio ≥100 ('Li'), and >1 focal lesion on MRI ('M'). Serum M-protein ≥3 g/dL alone indicates smoldering myeloma, not active myeloma.

Reference: Robbins & Cotran Pathologic Basis of Disease, 10th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Hematological Malignancies (Leukemias, Lymphomas, Myeloma) MCQs

See all Hematological Malignancies (Leukemias, Lymphomas, Myeloma) MCQs →